- $1.71bn
- $1.50bn
- $69.65m
U.S. STOCKS ON THE MOVE-Becton Dickinson, Constellation Energy, Marvell
Personalis slips as BTIG downgrades, sees no rival bid for Tempus deal
Brief: Personalis Receives New Task Order Under U.S. Veterans Affairs Contract For VA MVP
Personalis, Inc. reports results for the quarter ended June 30 - Earnings Summary
Personalis Q2 revenue rises 30%, beats estimates on expanded Medicare coverage
Brief: Personalis Q2 Net Income USD -31.683 Million
Personalis Inc expected to post a loss of 26 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Yum Brands, AMD, Nuvation Bio
U.S. STOCKS ON THE MOVE-Yum Brands, AMD, Nuvation Bio
Personalis slips after Tempus AI strikes $1.5 bln takeover deal
Tempus to buy cancer test maker Personalis for $1.5 billion (updated)
NASDAQ RESUMED AT 09:00 AM
Tempus to acquire Personalis for $1.5 billion
NASDAQ TRADE HALT HALT NEWS PENDING AT 08:25 AM
Brief: Personalis Secures Fourth Medicare Coverage Decision For Next Personal, Expanding Breast Cancer Coverage To Pre-Surgical Treatment Monitoring
U.S. STOCKS ON THE MOVE -Fervo, Sensata Technologies, Akamai
U.S. STOCKS ON THE MOVE-Chipmakers, Dynatrace, Alibaba
Personalis jumps on expanded Medicare coverage for cancer test
U.S. STOCKS ON THE MOVE-Nebius, US chipmakers, Assertio Holdings